Abstract: A patch includes an adhesive layer that includes (a) a drug, (b) a thermoplastic elastomer, and (c) non-volatile hydrocarbon oil having a kinematic viscosity of 60 mm2/s or less at 40° C. The (a) drug includes (i) an amino group that may have a substituent, and (ii) at least one functional group selected from the group consisting of an ester group, an amide group, an ether group, a thioether group, and an amino group different from the (i) amino group, all of which may have a substituent. The (a) has a structure, in which the (i) amino group, and the (ii) at least one functional group are bonded via a C1-C3 hydrocarbon chain. The number of hydroxyl groups per molecule of the (a) is 4 or less. An amount of the (c) is 230 parts by mass or less relative to 100 parts by mass of the (b).

Abstract: An image-forming apparatus includes a photosensitive drum, a development member, an intermediate transfer belt, a transfer member, a transfer voltage, a density detection unit, a temperature detection unit, and a control unit. The development member forms a toner image on a surface of the photosensitive drum, which the transfer member transfers to the intermediate transfer belt. The density detection unit detects an information related to a density of the toner image transferred to the intermediate transfer belt. The control unit controls a driving speed of the intermediate transfer belt. In a detection operation in which the density detection unit detects the information related to the density of the toner image transferred to the intermediate transfer belt in a state where the transfer voltage is applied to the transfer member, the control unit controls the driving speed based on an ambient temperature detected by the temperature detection unit.

Abstract: It is an object of the present invention to provide a formulation comprising ethyl cellulose, an active pharmaceutical ingredient, and a solvent, which is a stable formulation in which generation of impurities is suppressed even during the long-term storage. According to the present invention, provided is a formulation comprising (a) an active pharmaceutical ingredient, (b) ethyl cellulose, (c) 2-mercaptobenzimidazole, and (d) 0.1 part by weight or more of solvent with respect to 1 part by weight of the ethyl cellulose.

Abstract: A patch includes an adhesive laver, where the adhesive layer includes (a) 3-[(3R*,4R*)-3-(dimethylamionomethyl)tetrahydropyran-4-yl]phenol and (b) at least one selected from the group consisting of organic acids, amides, and alcohols, and an amount of the (b) is 50 parts by mass or greater relative to 100 parts mass of the (a). A production method of patch includes forming an adhesive layer with a mixture, where the mixture is obtained by mixing (a) 3-[(3R*,4R*)-3-(dimethylamionomethyl)tetrahydropyran-4-yl]phenol, and (b) a polar functional group-containing organic compound at 80° C. or lower.

Abstract: A patch includes: a support; and an adhesive layer on the support. The adhesive layer includes blonanserin or a salt thereof, a thermoplastic elastomer, and a higher fatty acid ester.

Abstract: The objective of the present invention is to provide a local anesthetic agent-containing patch having a skin permeability, cohesion force and adhesive property practical as a pharmaceutical product. The patch of the present invention is characterized in comprising a backing layer, and an adhesive layer on the backing layer, wherein the adhesive layer comprises at least a local anesthetic agent, a thermoplastic elastomer, a higher fatty acid ester, and a polyol fatty acid monoester, and a ratio of the higher fatty acid ester to 100 mass parts of the thermoplastic elastomer is 25 mass parts or more and 200 mass parts or less.

Abstract: It is an object of the present invention to provide a formulation comprising ethyl cellulose, an active pharmaceutical ingredient, and a solvent, which is a stable formulation in which generation of impurities is suppressed even during the long-term storage. According to the present invention, provided is a formulation comprising (a) an active pharmaceutical ingredient, (b) ethyl cellulose, (c) 2-mercaptobenzimidazole, and (d) 0.1 part by weight or more of solvent with respect to 1 part by weight of the ethyl cellulose.

Abstract: It is an object of the present invention to provide an adhesive sheet for skin patch, having adhesive force and cohesive force that are practicable as a pharmaceutical product and exhibiting high drug solubility and sufficient drug skin permeability. According to the present invention, provided is an adhesive sheet for skin patch, having an adhesive layer on a support, wherein the adhesive layer comprises, at least, a thermoplastic elastomer and a long-chain branched alcohol having a total carbon number of 13 or more, the long-chain branched alcohol is comprised in an amount of 40 parts by weight or more and 200 parts by weight or less, with respect to 100 parts by weight of the thermoplastic elastomer, and the adhesive layer does not comprise a tackifier, or comprises a tackifier in an amount of 30% by weight or less, with respect to the amount of the entire adhesive layer.

Abstract: The present invention provides a patch containing an adhesive layer maintaining a drug, which is formed on a support, wherein the aforementioned adhesive layer comprises a thermoplastic elastomer, a non-volatile hydrocarbon oil in an amount exceeding 50 parts by weight and not more than 800 parts by weight per 100 parts by weight of the elastomer, and rivastigmine or a salt thereof, and the aforementioned adhesive layer optionally further contains a tackifier at a content in the adhesive layer of not more than 10 wt %.

Abstract: Provided is an adhesive sheet for adhesion to the skin, which has sufficient adhesiveness and causes low skin irritation. The adhesive sheet comprises a support and an adhesive layer formed on the support, in which the adhesive layer contains at least a thermoplastic elastomer and a non-volatile hydrocarbon oil. Further provided is a transdermal absorption preparation having sufficient adhesiveness and drug releaseability and causes low skin irritation. The transdermal absorption preparation comprises an adhesive sheet as described herein and a drug or a pharmaceutically acceptable salt thereof that is contained in the adhesive layer of the sheet.

Abstract: It is an object of the present invention to provide an efinaconazole-containing film-forming preparation, which has no sticky surface after solidification thereof, has sufficient cohesiveness after solidification thereof, and is easily peeled without washing. The present invention provides a therapeutic preparation for onychomycosis, comprising efinaconazole or a salt thereof, 1% by weight or more and 30% by weight or less of ethyl cellulose, 20% by weight or more of a volatile solvent (wherein the volatile solvent is water or a liquid component having a boiling point lower than that of water), and 0.01% by weight or more and less than 30% by weight of a surfactant.

Abstract: It is an object of the present invention to provide a patch having practical adhesive force and cohesive force as a pharmaceutical product, and also exhibiting a fast-acting anesthetic action. The present invention provides a patch formed from an adhesive layer comprising 5% by weight or more and less than 20% by weight of a mixture of lidocaine and another local anesthetic, wherein the adhesive layer comprises at least a rubber-based pressure-sensitive adhesive and liquid paraffin and a content of a tackifier in the adhesive layer is 10% by weight or less.

Abstract: A charge control method for an alkaline storage battery includes determining whether or not a temperature T of a battery is less than 0° C.; if the temperature T is equal to or higher than 0° C., determining whether or not the battery has been considered to be charged to a maximum capacity that can be stored in the battery; if the battery has not been considered to be charged to the maximum capacity, determining the temperature T of the battery again; if the battery has been considered to be charged to the maximum capacity, finishing the charging; if it is determined that the temperature T is less than 0° C.

Abstract: A charge control method for an alkaline storage battery includes determining whether or not a temperature T of a battery is less than 0° C.; if the temperature T is equal to or higher than 0° C., determining whether or not the battery has been considered to be charged to a maximum capacity that can be stored in the battery; if the battery has not been considered to be charged to the maximum capacity, determining the temperature T of the battery again; if the battery has been considered to be charged to the maximum capacity, finishing the charging; if it is determined that the temperature T is less than 0° C.

Abstract: The invention provides an adhesive sheet for skin, which shows sufficient adhesiveness to the skin and causes low skin irritation. The adhesive sheet contains an adhesive layer formed on a support, in which the adhesive layer contains at least a thermoplastic elastomer, a non-volatile hydrocarbon oil, and polyisobutylene, but no tackifier. The polyisobutylene is a medium molecular weight polyisobutylene with a viscosity average molecular weight of more than 100,000 and not more than 500,000. The invention also provides a percutaneous absorption preparation containing a drug or a pharmaceutically acceptable salt thereof in an adhesive layer of the inventive adhesive sheet for skin.

Abstract: A conductive film includes a layer 1 formed by a conductive material 1 that includes a polymer material 1 containing any of (1) an amine and an epoxy resin (where the epoxy resin and the amine are mixed in a ratio of 1.0 or more in terms of the ratio of the number of active hydrogen atoms in the amine with respect to the number of functional groups in the epoxy resin), (2) a phenoxy resin and an epoxy resin, (3) a saturated hydrocarbon polymer having a hydroxyl group, and (4) a curable resin and an elastomer and conductive particles 1. The conductive film has excellent stability in an equilibrium potential environment in a negative electrode and low electric resistance per unit area in the thickness direction. A multilayer conductive film including the conductive film achieves excellent interlayer adhesion, and using them as a current collector enables the production of a battery satisfying both weight reduction and durability.

Abstract: It is an object of the present invention to provide a patch having practical adhesive force and cohesive force as a pharmaceutical product, and also exhibiting a fast-acting anesthetic action. The present invention provides a patch formed from an adhesive layer comprising 5% by weight or more and less than 20% by weight of a mixture of lidocaine and another local anesthetic, wherein the adhesive layer comprises at least a rubber-based pressure-sensitive adhesive and liquid paraffin and a content of a tackifier in the adhesive layer is 10% by weight or less.

Abstract: An image capturing apparatus comprises an object detection unit, a focus control unit, a shooting control unit, a focus detection unit, a prediction unit which predicts a position of the object, a setting unit which sets a focus detection area with respect to the position of the predicted object, a reliability acquisition unit which obtains a reliability regarding the focus detection area and an object moving amount acquisition unit which obtains a moving amount of the object based on the in-focus positions of the imaging optical system. Until the object detection result is obtained before the real shooting processing during continuous shooting, the focus control unit drives the imaging optical system based on the in-focus position indicated by detection results up until the previous real shooting processing, the reliability and the moving amount of the object.

Abstract: A patch containing a storage layer retaining a drug or a pharmaceutically acceptable salt thereof and an adhesive layer which are formed on a support, wherein the adhesive layer contains a thermoplastic elastomer, and a non-volatile hydrocarbon oil in more than 50 parts by weight and not more than 800 parts by weight per 100 parts by weight of the elastomer, and the adhesive layer optionally further contains a tackifier at a content of not more than 10 wt %.

Abstract: The present invention provides an adhesive sheet for skin, which shows sufficient adhesiveness to the skin and causes low skin irritation. The first adhesive sheet for skin of the present invention has an adhesive layer formed on a support, wherein the aforementioned adhesive layer contains at least a thermoplastic elastomer, non-volatile hydrocarbon oil and polyisobutylene having a viscosity average molecular weight of more than 100,000 and not more than 500,000, and does not contain a tackifier.